2020 Patient Support Vendor Directory

A panel of experts examines how stakeholders can support strategies that improve patient outcomes, while also navigating various distribution models.

Renier Brentjens, MD, PhD outlines the evolution of the space, while offering ways to boost patient access to these treatments.

The Carlsbad plant is expected to accelerate both the development and commercialization of cell therapies.

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

A panel discussion uncovers ways to deliver personalized therapy ops in a timely fashion.

The key strategies for reducing or eliminating post-prescription abandonment.